CIPLA & BMS may settle patent dispute over Entecavir in India
30th May, 2015 - 12:16 pm
Categories:
IPAB
IPAB Decisions
News & Updates
patent infringement
Patents
pharma
0 Comments
US based pharma major Bristol-Myers Squibb (BMS) and Indian pharma company Cipla Ltd. are heading towards an amicable settlement on a long-stretched patent dispute concerning BMS’ hepatitis B drug Entecavir, a leading anti-viral drug for Hepatitis B patients that brings in more than a billion dollars each year globally for BMS. Entecavir, being a pre-1995 … Continue reading CIPLA & BMS may settle patent dispute over Entecavir in India
Read more »